Literature DB >> 15996647

Messenger RNA expression of glomerular podocyte markers in the urinary sediment of acquired proteinuric diseases.

Cheuk-Chun Szeto1, Ka-Bik Lai, Kai-Ming Chow, Carol Yi-Ki Szeto, Thomas Wai-Cheong Yip, Kam-Sang Woo, Philip Kam-Tao Li, Fernand Mac-Moune Lai.   

Abstract

BACKGROUND: Podocyte slit diaphragm plays an important role in the control of glomerular permeability. We hypothesize that studying the gene expression profile of podocyte in urinary sediment may provide diagnostic and prognostic information on acquired proteinuric diseases.
METHODS: We studied 28 patients who required kidney biopsy for acquired proteinuric diseases (diabetic glomerulosclerosis, 9 cases; IgA nephropathy, 10 cases; minimal change disease, 5 cases; membranous nephropathy, 5 cases). We also studied 10 cases of diabetic microalbuminuria and 9 healthy controls. The mRNA expressions of nephrin (NephRNA), podocin (PodRNA) and synaptopodin (SynRNA) in urinary sediment were measured by real time quantitative PCR. After recruitment, all patients were followed for at least 12 months.
RESULTS: There were significant differences in the NephRNA and PodRNA in the urinary sediment between diagnosis groups (p<0.005). On the other hand, SynRNA was only marginally significant between diagnosis groups (p<0.05). Although statistically significant, the degree of proteinuria had only modest correlations with the urinary expression of nephrin. After a median follow up for 23 months, there was a significant correlation between the rate of decline in renal function and NephRNA (r=0.559, p=0.001) and PodRNA (r=0.530, p=0.002), but not SynRNA (r=0.054, p=NS). The correlation remained statistically significant after multivariate analysis to adjust for the degree of proteinuria and initial renal function.
CONCLUSIONS: Urinary mRNA expression of podocyte markers, such as nephrin and podocin, are significantly different between proteinuric disease categories. Further, NephRNA and PodRNA correlated with the rate of decline in renal function. Our results suggest that urinary podocyte gene expression may be a useful non-invasive tool which provides additional information for the management of proteinuric diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15996647     DOI: 10.1016/j.cccn.2005.05.016

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  28 in total

1.  Angiotensin II-dependent persistent podocyte loss from destabilized glomeruli causes progression of end stage kidney disease.

Authors:  Akihiro Fukuda; Larysa T Wickman; Madhusudan P Venkatareddy; Yuji Sato; Mahboob A Chowdhury; Su Q Wang; Kerby A Shedden; Robert C Dysko; Jocelyn E Wiggins; Roger C Wiggins
Journal:  Kidney Int       Date:  2011-09-21       Impact factor: 10.612

Review 2.  Genomic biomarkers for chronic kidney disease.

Authors:  Wenjun Ju; Shahaan Smith; Matthias Kretzler
Journal:  Transl Res       Date:  2012-02-09       Impact factor: 7.012

3.  Urine podocyte mRNAs, proteinuria, and progression in human glomerular diseases.

Authors:  Larysa Wickman; Farsad Afshinnia; Su Q Wang; Yan Yang; Fei Wang; Mahboob Chowdhury; Delia Graham; Jennifer Hawkins; Ryuzoh Nishizono; Marie Tanzer; Jocelyn Wiggins; Guillermo A Escobar; Bradley Rovin; Peter Song; Debbie Gipson; David Kershaw; Roger C Wiggins
Journal:  J Am Soc Nephrol       Date:  2013-09-19       Impact factor: 10.121

Review 4.  The emerging role of biomarkers in diabetic and hypertensive chronic kidney disease.

Authors:  Kunal Chaudhary; Gautam Phadke; Ravi Nistala; Charles E Weidmeyer; Samy I McFarlane; Adam Whaley-Connell
Journal:  Curr Diab Rep       Date:  2010-02       Impact factor: 4.810

5.  Discovery of genes related to diabetic nephropathy in various animal models by current techniques.

Authors:  Jun Wada; Lin Sun; Yashpal S Kanwar
Journal:  Contrib Nephrol       Date:  2011-01-20       Impact factor: 1.580

6.  Conditionally immortalized human podocyte cell lines established from urine.

Authors:  Toru Sakairi; Yoshifusa Abe; Hiroshi Kajiyama; Linda D Bartlett; Lilian V Howard; Parmijit S Jat; Jeffrey B Kopp
Journal:  Am J Physiol Renal Physiol       Date:  2009-12-02

7.  Expression patterns of podocyte-associated mRNAs in patients with proliferative or non-proliferative glomerulopathies.

Authors:  Patrícia Garcia Rodrigues; Rafael Nazário Bringhenti; Jonathan Frapporti do Nascimento; Gabriel Joelsons; Mariane dos Santos; Sane Pereira; Francisco Veríssimo Veronese
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

8.  Urinary and glomerular podocytes in patients with chronic kidney diseases.

Authors:  Kikuno Hanamura; Akihiro Tojo; Toshiro Fujita
Journal:  Clin Exp Nephrol       Date:  2013-05-15       Impact factor: 2.801

9.  Urine podocyte mRNAs mark progression of renal disease.

Authors:  Yuji Sato; Bryan L Wharram; Sang Koo Lee; Larysa Wickman; Meera Goyal; Madhusudan Venkatareddy; Jai Won Chang; Jocelyn E Wiggins; Chrysta Lienczewski; Matthias Kretzler; Roger C Wiggins
Journal:  J Am Soc Nephrol       Date:  2009-04-23       Impact factor: 10.121

10.  Expression of mRNA for functional molecules in urinary sediment in glomerulonephritis.

Authors:  Koji Tsugawa; Eishin Oki; Koichi Suzuki; Tadaatsu Imaizumi; Etsuro Ito; Hiroshi Tanaka
Journal:  Pediatr Nephrol       Date:  2007-12-19       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.